On Friday, Ardelyx Inc (ARDX) stock saw a modest uptick, ending the day at $6.65 which represents a slight increase of $0.29 or 4.56% from the prior close of $6.36. The stock opened at $6.43 and ...

On Friday, Align Technology, Inc. (ALGN) stock saw a modest uptick, ending the day at $254.81 which represents a slight increase of $5.35 or 2.14% from the prior close of $249.46. The stock opened at ...

Fintel reports that on September 27, 2024, Leerink Partners downgraded their outlook for Agios Pharmaceuticals (NasdaqGS:AGIO ...

Leerink Partners analyst Roanna Ruiz maintained a Hold rating on Enanta Pharmaceuticals (ENTA – Research Report) yesterday. The ...

Agios Pharmaceuticals (AGIO) stock was downgraded at Leerink Partners on Pfizer's (PFE) recent decision to withdraw sickle ...

Leerink Partners analyst Puneet Souda reiterated a Buy rating on Quanterix (QTRX – Research Report) today. The company’s shares ...

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or other jurisdiction in which such an offer ...

Medicines the company is developing for eczema and myasthenia gravis met their objectives in Phase 3 trials. But analysts weren’t convinced they can compete with available alternatives.

Capstan Therapeutics to participate in Goldman Sachs Cell Therapy Day 2024 and Leerink Partners Biopharma Private Company Connect.

Regeneron (REGN) stock was downgraded by Leerink after a court ruling that favored Amgen's (AMGN) plans to introduce a biosimilar for REGN's Eylea. Read more here.

MannKind Corporation (NASDAQ:MNKD) is a U.S.-based biopharmaceutical company focused on developing and commercializing ...